ArticleResearch square2025
Divergent alterations in the skeletal muscle and serum proteome in a rodent model of anorexia nervosa and weight recovery.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Anorexia nervosa (AN) is a severe psychiatric disorder characterized by prolonged caloric restriction and significant weight loss, including loss of skeletal muscle. However, physiological changes during AN and following weight restoration are poorly understood, especially skeletal muscle physiology and how it relates to systemic physiology. In this study, we utilized a rodent model of AN and weight gain to investigate proteomic changes across the skeletal muscle and serum and how these proteomic alterations relate to muscle functional outcomes. Using SOMAscan proteomics, we identified extensive alterations in the skeletal muscle proteome during 30 days of simulated AN, with the majority of these changes persisting after weight restoration. Muscle mass and strength were not fully recovered after weight restoration, aligning with sustained dysregulation of proteins related to apoptosis, calcium handling, and satellite cell proliferation in skeletal muscle. By contrast, serum proteomic changes were modest during AN but markedly altered and largely distinct from muscle during recovery. TRAIL (TNF-related apoptosis-inducing ligand) emerged as a potential non-invasive biomarker of muscle health as TRAIL content correlated between muscle and serum as well as muscle functional assessments. Proteomic biomarkers of muscle versus systemic AN are largely unique, underlining the complexity of this illness and the need for novel analytical approaches; however, TRAIL dysregulation may be a conserved feature across tissues and should be further investigated as potential non-invasive biomarker of muscle health and a possible mechanistic target for AN-induced muscle loss.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.